A Phase I Study of ZD0473 and Doxil [liposomal doxorubicin] in Patients With Advanced Refractory Cancer
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2008
At a glance
- Drugs Doxorubicin liposomal; Picoplatin
- Indications Ovarian cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2008 Status changed rom recruiting to completed as reported in ASCO abstract.
- 06 Jun 2008 Final results presented as ASCO 2008.